6.28
2.94%
-0.19
Biocryst Pharmaceuticals Inc. 주식(BCRX)의 최신 뉴스
New York State Common Retirement Fund Sells 17821 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Defense World
Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals (BCRX) Stock? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
BioCryst Pharmaceuticals Shares Rise 20% Following Disclosure of Executive Share Purchases - Marketscreener.com
Marketscreener.com
Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com Canada
Investing.com Canada
Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com Australia
Investing.com Australia
Biocryst Pharmaceuticals director buys $120k in stock By Investing.com - Investing.com Australia
Investing.com Australia
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com Australia
Investing.com Australia
BioCryst Pharmaceuticals CFO buys $202k in company stock - Investing.com Australia
Investing.com Australia
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com Canada
Investing.com Canada
Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com Canada
Investing.com Canada
Steven K. Galson Purchases 21,940 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock - MarketBeat
MarketBeat
Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com
Investing.com
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up Following Insider Buying Activity - MarketBeat
MarketBeat
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30000 Shares of BioCryst ... - Yahoo Finance
Yahoo Finance
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance
Yahoo Finance
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance
Yahoo Finance
Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance
Yahoo Finance
BioCryst stock spikes on insider purchases (NASDAQ:BCRX) - Seeking Alpha
Seeking Alpha
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com
Investing.com
Biocryst Pharmaceuticals CFO purchases $202k in company stock - Investing.com
Investing.com
BioCryst Pharmaceuticals CFO buys $202k in company stock - Investing.com
Investing.com
Biocryst Pharmaceuticals CFO purchases $202k in company stock - Investing.com UK
Investing.com UK
Biocryst Pharmaceuticals director buys $120k in stock By Investing.com - Investing.com UK
Investing.com UK
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com UK
Investing.com UK
Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com UK
Investing.com UK
Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com UK
Investing.com UK
What Kind Of Shareholders Hold The Majority In BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shares? - Yahoo New Zealand News
Yahoo New Zealand News
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology - GlobeNewswire
GlobeNewswire
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
GlobeNewswire Inc.
Mexico approves BioCryst's HAE drug ORLADEYO - Investing.com India
Investing.com India
BioCryst Pharmaceuticals (BCRX) in Focus: Stock Moves 8.5% Higher - Yahoo Movies UK
Yahoo Movies UK
BioCryst (BCRX) Provides Updates on Galidesivir, Shares Fall - Yahoo Singapore News
Yahoo Singapore News
Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals (BCRX) Stock? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Mexico approves BioCryst's HAE drug ORLADEYO By Investing.com - Investing.com
Investing.com
Mexico approves BioCryst's HAE drug ORLADEYO By Investing.com - Investing.com UK
Investing.com UK
ORLADEYO® (berotralstat) Approved in Mexico - GlobeNewswire
GlobeNewswire
ORLADEYO® (berotralstat) Approved in Mexico - Yahoo Finance
Yahoo Finance
Are Institutions Heavily Invested In BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shares? - Yahoo News UK
Yahoo News UK
Los Angeles Capital Management LLC Has $319000 Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Defense World
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) institutional shareholders had a great week as one-year returns ... - Yahoo Canada Shine On
Yahoo Canada Shine On
BioCryst Pharmaceuticals, Inc. to Post Q2 2024 Earnings of ($0.14) Per Share, HC Wainwright Forecasts (NASDAQ ... - Defense World
Defense World
Research Analysts Issue Forecasts for BioCryst Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:BCRX) - MarketBeat
MarketBeat
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization ... - GlobeNewswire
GlobeNewswire
Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results - Yahoo Finance
Yahoo Finance
FY2028 EPS Estimates for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Reduced by Analyst - Defense World
Defense World
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Forecasted to Earn FY2028 Earnings of $1.31 Per Share - MarketBeat
MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) Given New $15.00 Price Target at JMP Securities - Defense World
Defense World
BioCryst Pharmaceuticals (NASDAQ:BCRX) Receives Buy Rating from Needham & Company LLC - Defense World
Defense World
BioCryst Pharmaceuticals (NASDAQ:BCRX) Issues Earnings Results - MarketBeat
MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Up 5.5% on Strong Earnings - MarketBeat
MarketBeat
자본화:
|
볼륨(24시간):